Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Russell F Palm"'
Autor:
JM Bryant, Russell F Palm, Roberto Herrera, Muni Rubens, Sarah E Hoffe, Dae Won Kim, Adeel Kaiser, Antonio Ucar, Jason Fleming, Fernando De Zarraga, Pamela Hodul, Santiago Aparo, Horacio Asbun, Mokenge Malafa, Ramon Jimenez, Jason Denbo, Jessica M Frakes, Michael D. Chuong
Publikováno v:
Cancer Control, Vol 30 (2023)
Purpose Treatment options for pancreatic ductal adenocarcinoma (PDAC) are commonly limited for patients with advanced age due to medical comorbidities and/or poor performance status. These patients may not be candidates for more aggressive chemothera
Externí odkaz:
https://doaj.org/article/98fa1c6c7c71415db1998dca42512612
Autor:
Russell F. Palm, MD, Casey L. Liveringhouse, MD, Ricardo J. Gonzalez, MD, Marilyn M. Bui, MD, Odion Binitie, MD, George Q. Yang, MD, Arash O. Naghavi, MD, MS
Publikováno v:
Advances in Radiation Oncology, Vol 8, Iss 1, Pp 101086- (2023)
Purpose: Whether the therapeutic response of soft-tissue sarcoma to neoadjuvant treatment is predictive for clinical outcomes is unclear. Given the rarity of this disease and the confounding effects of chemotherapy, this study analyzes whether a favo
Externí odkaz:
https://doaj.org/article/28a4241db1bc41f380e576f43076e2f6
Autor:
J.M. Bryant, MD, Russell F. Palm, MD, Casey Liveringhouse, MD, Emanuel Boyer, BS, Pam Hodul, MD, Mokenge Malafa, MD, Jason Denbo, MD, Dae Kim, MD, Estrella Carballido, MD, Jason B. Fleming, MD, Sarah Hoffe, MD, Jessica Frakes, MD
Publikováno v:
Advances in Radiation Oncology, Vol 7, Iss 6, Pp 101045- (2022)
Purpose: Preoperative radiation therapy (RT) for pancreatic adenocarcinoma reduces positive surgical margin rates, and when delivered to an ablative dose range it may improve local control and overall survival for patients with unresectable disease.
Externí odkaz:
https://doaj.org/article/a3f90e7027624f128e1f57c09ed1e7d5
Autor:
Austin J. Sim, Russell F. Palm, Kirby B. DeLozier, Vladimir Feygelman, Kujtim Latifi, Gage Redler, Iman R. Washington, Evan J. Wuthrick, Stephen A. Rosenberg
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 25, Iss , Pp 102-106 (2020)
Aims: To assess the safety and efficacy of MR-guided stereotactic body radiation therapy (MRgSBRT) for cardiac metastases. Materials/methods: This single institution retrospective analysis evaluated our experience with MRgSBRT for cardiac metastases.
Externí odkaz:
https://doaj.org/article/302db9ecad0b4c8097eb27de69eaf378
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 22, Iss , Pp 22-28 (2020)
Background and purpose: Retroperitoneal sarcoma (RPS) is a rare, complex disease requiring multidisciplinary management. We have previously reported that use of the Revised Edmonton Symptom Assessment Scale (ESAS-r-CSS) allows for proactive symptom m
Externí odkaz:
https://doaj.org/article/e1f7778e385443a6a8172ca8cd5a54df
Publikováno v:
Surgical Oncology Clinics of North America. 32:599-615
Autor:
Russell F. Palm, Emanuel Boyer, Dae W. Kim, Jason Denbo, Pamela J. Hodul, Mokenge Malafa, Jason B. Fleming, Ravi Shridhar, Michael D. Chuong, Eric A. Mellon, Jessica M. Frakes, Sarah E. Hoffe
Publikováno v:
HPB.
Publikováno v:
Annals of Surgical Oncology.
Autor:
Dilmurodjon Eshmuminov, Botirjon Aminjonov, Russell F. Palm, Giuseppe Malleo, Ryan K. Schmocker, Raëf Abdallah, Changhoon Yoo, Walid L. Shaib, Marcel André Schneider, Elena Rangelova, Yoo Jin Choi, Hongbeom Kim, J. Bart Rose, Sameer Patel, Gregory C. Wilson, Sarah Maloney, Lea Timmermann, Klaus Sahora, Fabian Rössler, Víctor Lopez-Lopez, Emanuel Boyer, Laura Maggino, Thomas Malinka, Jeong Youp Park, Matthew H. G. Katz, Laura Prakash, Syed A. Ahmad, Scott Helton, Jin-Young Jang, Sarah E. Hoffe, Roberto Salvia, Julien Taieb, Jin He, Pierre-Alain Clavien, Ulrike Held, Kuno Lehmann
Publikováno v:
Annals of Surgical Oncology.
Autor:
Dilmurodjon Eshmuminov, Botirjon Aminjonov, Russell F. Palm, Giuseppe Malleo, Ryan K. Schmocker, Raëf Abdallah, Changhoon Yoo, Walid L. Shaib, Marcel André Schneider, Elena Rangelova, Yoo Jin Choi, Hongbeom Kim, J. Bart Rose, Sameer Patel, Gregory C. Wilson, Sarah Maloney, Lea Timmermann, Klaus Sahora, Fabian Rössler, Víctor Lopez-Lopez, Emanuel Boyer, Laura Maggino, Thomas Malinka, Jeong Youp Park, Matthew H. G. Katz, Laura Prakash, Syed A. Ahmad, Scott Helton, Jin-Young Jang, Sarah E. Hoffe, Roberto Salvia, Julien Taieb, Jin He, Pierre-Alain Clavien, Ulrike Held, Kuno Lehmann
Publikováno v:
Annals of Surgical Oncology.
Background Pancreatic cancer often presents as locally advanced (LAPC) or borderline resectable (BRPC). Neoadjuvant systemic therapy is recommended as initial treatment. It is currently unclear what chemotherapy should be preferred for patients with